Transdermal delivery of adriamycin to transplanted ehrlich ascites tumor in mice

Masataka Shiozuka, Yoshiaki Nonomura, Ryoichi Matsuda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

There is considerable interest in the skin as a site of anti-cancer drug application. Nevertheless, the skin poses a formidable barrier to drug penetration, thereby limiting topical and transdermal bioavailability. However, we previously showed that a thioglycolate-based depilatory agent increases the drug permeability of mouse skin. In the present report, we investigated the skin permeability and efficacy of the anti-cancer drug adriamycin increased when administered transdermally to mice in combination with a thioglycolate-based depilatory agent. Adriamycin in combination with depilatory treatment reduced Ehrlich tumor growth in hairless mice about the weight and size of harvested tumors. In addition, our delivery method for adriamycin increased the therapeutic effectiveness of this agent by decreasing toxicity. Moreover, measurement of adriamycin autofluorescence revealed that topically applied adriamycin penetrate the dermis after depilatory agent treatment. These results indicate that the transdermal delivery of anti-cancer drugs is feasible by handy pretreatment of the skin with a thioglycolate-based depilatory agent.

Original languageEnglish
Pages (from-to)385-391
Number of pages7
JournalPharmaceutics
Volume5
Issue number3
DOIs
Publication statusPublished - Jul 11 2013

Fingerprint

Ehrlich Tumor Carcinoma
Doxorubicin
Thioglycolates
Skin
Pharmaceutical Preparations
Neoplasms
Permeability
Hairless Mouse
Dermis
Biological Availability
Weights and Measures
Growth

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Transdermal delivery of adriamycin to transplanted ehrlich ascites tumor in mice. / Shiozuka, Masataka; Nonomura, Yoshiaki; Matsuda, Ryoichi.

In: Pharmaceutics, Vol. 5, No. 3, 11.07.2013, p. 385-391.

Research output: Contribution to journalArticle

Shiozuka, Masataka ; Nonomura, Yoshiaki ; Matsuda, Ryoichi. / Transdermal delivery of adriamycin to transplanted ehrlich ascites tumor in mice. In: Pharmaceutics. 2013 ; Vol. 5, No. 3. pp. 385-391.
@article{d53c810b96124fa5855e9749575c1c8e,
title = "Transdermal delivery of adriamycin to transplanted ehrlich ascites tumor in mice",
abstract = "There is considerable interest in the skin as a site of anti-cancer drug application. Nevertheless, the skin poses a formidable barrier to drug penetration, thereby limiting topical and transdermal bioavailability. However, we previously showed that a thioglycolate-based depilatory agent increases the drug permeability of mouse skin. In the present report, we investigated the skin permeability and efficacy of the anti-cancer drug adriamycin increased when administered transdermally to mice in combination with a thioglycolate-based depilatory agent. Adriamycin in combination with depilatory treatment reduced Ehrlich tumor growth in hairless mice about the weight and size of harvested tumors. In addition, our delivery method for adriamycin increased the therapeutic effectiveness of this agent by decreasing toxicity. Moreover, measurement of adriamycin autofluorescence revealed that topically applied adriamycin penetrate the dermis after depilatory agent treatment. These results indicate that the transdermal delivery of anti-cancer drugs is feasible by handy pretreatment of the skin with a thioglycolate-based depilatory agent.",
author = "Masataka Shiozuka and Yoshiaki Nonomura and Ryoichi Matsuda",
year = "2013",
month = "7",
day = "11",
doi = "10.3390/pharmaceutics5030385",
language = "English",
volume = "5",
pages = "385--391",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

TY - JOUR

T1 - Transdermal delivery of adriamycin to transplanted ehrlich ascites tumor in mice

AU - Shiozuka, Masataka

AU - Nonomura, Yoshiaki

AU - Matsuda, Ryoichi

PY - 2013/7/11

Y1 - 2013/7/11

N2 - There is considerable interest in the skin as a site of anti-cancer drug application. Nevertheless, the skin poses a formidable barrier to drug penetration, thereby limiting topical and transdermal bioavailability. However, we previously showed that a thioglycolate-based depilatory agent increases the drug permeability of mouse skin. In the present report, we investigated the skin permeability and efficacy of the anti-cancer drug adriamycin increased when administered transdermally to mice in combination with a thioglycolate-based depilatory agent. Adriamycin in combination with depilatory treatment reduced Ehrlich tumor growth in hairless mice about the weight and size of harvested tumors. In addition, our delivery method for adriamycin increased the therapeutic effectiveness of this agent by decreasing toxicity. Moreover, measurement of adriamycin autofluorescence revealed that topically applied adriamycin penetrate the dermis after depilatory agent treatment. These results indicate that the transdermal delivery of anti-cancer drugs is feasible by handy pretreatment of the skin with a thioglycolate-based depilatory agent.

AB - There is considerable interest in the skin as a site of anti-cancer drug application. Nevertheless, the skin poses a formidable barrier to drug penetration, thereby limiting topical and transdermal bioavailability. However, we previously showed that a thioglycolate-based depilatory agent increases the drug permeability of mouse skin. In the present report, we investigated the skin permeability and efficacy of the anti-cancer drug adriamycin increased when administered transdermally to mice in combination with a thioglycolate-based depilatory agent. Adriamycin in combination with depilatory treatment reduced Ehrlich tumor growth in hairless mice about the weight and size of harvested tumors. In addition, our delivery method for adriamycin increased the therapeutic effectiveness of this agent by decreasing toxicity. Moreover, measurement of adriamycin autofluorescence revealed that topically applied adriamycin penetrate the dermis after depilatory agent treatment. These results indicate that the transdermal delivery of anti-cancer drugs is feasible by handy pretreatment of the skin with a thioglycolate-based depilatory agent.

UR - http://www.scopus.com/inward/record.url?scp=84880378441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880378441&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics5030385

DO - 10.3390/pharmaceutics5030385

M3 - Article

AN - SCOPUS:84880378441

VL - 5

SP - 385

EP - 391

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 3

ER -